Business Wire

TOSHIBA/UT-FORTEM

22.3.2021 23:02:06 CET | Business Wire | Press release

Share
Toshiba Executes Strategic Alliance Agreement and Invests in Counter-Drone Security Company Fortem Technologies, Inc.

Toshiba Corporation (TOKYO:6502) today announced that Toshiba Infrastructure Systems & Solutions Corporation, the Toshiba Group company specializing in the global infrastructure business (hereinafter Toshiba), has entered into a strategic business alliance with Fortem Technologies, Inc. (hereafter Fortem), and invested 15 million USD in the company. Fortem is a technology leader in counter-drone security and Toshiba, through the alliance, aims to expand its radar-based security solutions business.

Based in Utah, US, Fortem is a drone security company that has grown rapidly in recent years by supplying leading counter-drone systems, notably highly accurate small drone detection radars that are easily installed, and autonomous drones that can capture rogue drones in a net.

“Toshiba is a world-renowned technical and sales powerhouse,” said Timothy Bean, CEO of Fortem. “We are very pleased to announce this alliance to accelerate the delivery of solutions to our customers that combine the disruptive innovation of our AI-enabled Fortem SkyDome System with the depth of Toshiba’s commercial drone RF detection expertise and advanced radar technology. This partnership brings added confidence to security professionals who must secure the airspace above their venues, campuses and metro regions.”

Toshiba has already commercialized a drone detection system that plots incoming direction and altitude from radio waves emitted by the drone in flight. ​Toshiba is also strengthening its drone security business through research and development of related products.

The alliance will integrate Toshiba and Fortem’s highly complementary systems to realize more effective, multi-layered counter-drone solutions and services, and expand sales in Japan and the US, and in promising overseas markets, including those of Asia, Europe, the Middle East, with mutual access to each other’s sales network.

Masaki Haruyama, Vice President of Toshiba said, “We are excited to partner with Fortem, a pioneering counter-drone solution provider with proven detection system and unique and highly effective interception system. Toshiba has a long history of providing leading technologies of radars. With the perfectly complementary technologies and products of the two companies, we are confident that we can become a global top-tier player in a rapidly growing market, and contribute a safer, more reliable facilities.

Going forward, Toshiba will contribute to ensuring infrastructure security through the alliance with Fortem, by responding to the growing need to prevent damage caused by suspicious drones at airports and other critical facilities, stadiums and other large venues, and private properties around the world. Toshiba aims to win annual sales of 30 billion JPY in the counter-drone security business by FY2030.

About Fortem Technologies, Inc.

  1. Founded: 2016
  2. Representative: Timothy Bean
  3. Headquarters: Utah, the United States
  4. Employees: Over 100 people
  5. Business: Counter-drone security products and services

About Toshiba Corporation

Toshiba Corporation leads a global group of companies that combines knowledge and capabilities from over 140 years of experience in a wide range of businesses—from energy and social infrastructure to electronic devices—with world-class capabilities in information processing, digital and AI technologies. These distinctive strengths support Toshiba’s continued evolution toward becoming an Infrastructure Services Company that promotes data utilization and digitization, and one of the world’s leading cyber-physical-systems technology companies. Guided by the Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future,” Toshiba contributes to society’s positive development with services and solutions that lead to a better world. The Group and its 130,000 employees worldwide secured annual sales surpassing 3.4 trillion yen in FY2019.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 07:30:00 CET | Press release

Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob

Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 06:30:00 CET | Press release

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan

VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 01:00:00 CET | Press release

Enabling Next-Generation High-Performance Automotive Camera Systems VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise

Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 22:30:00 CET | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 22:30:00 CET | Press release

Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye